Clinical Trials Directory

Trials / Completed

CompletedNCT00140361

Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria

Assessing and Monitoring the Efficacy of Sulfadoxine/ Pyrimethamine (SP) and the Combination of SP Plus Artesunate for Uncomplicated Malaria Infections Among Children

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
390 (actual)
Sponsor
Centers for Disease Control and Prevention · Federal
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is an ongoing monitoring activity of efficacy of sulfadoxine-pyrimethamine (SP), which is the current national treatment of choice for uncomplicated malaria in Tanzania, and a combination of SP and artesunate among children \< 5 years in 3 sites in rural Tanzania. Protocol was amended in 2004 to (1) include lumefantrine+artemether, the newly identified first-line treatment for malaria to be introduced into Tanzania in 2006; (2) on a limited basis, include adult patients; (3) extend follow-up to 28 days; (4) investigate whether treated bednets would reduce confounding by reinfection

Detailed description

This is an ongoing monitoring activity of efficacy of sulfadoxine-pyrimethamine (SP), which is the current national treatment of choice for uncomplicated malaria in Tanzania, and a combination of SP and artesunate among children \< 5 years in 3 sites in rural Tanzania. Protocol was amended in 2004 to (1) include lumefantrine+artemether, the newly identified first-line treatment for malaria to be introduced into Tanzania in 2006; (2) on a limited basis, include adult patients; (3) extend follow-up to 28 days; (4) investigate whether treated bednets would reduce confounding by reinfection

Conditions

Interventions

TypeNameDescription
DRUGSulfadoxine-pyrimethamine
DRUGsulfadoxine-pyrimethamine plus artesunate
DRUGlumefantrine plus artemether
BEHAVIORALSleeping under insecticide-treated bednet

Timeline

Start date
2000-01-01
Primary completion
2008-01-01
Completion
2008-01-01
First posted
2005-09-01
Last updated
2012-09-11

Locations

3 sites across 1 country: Tanzania

Source: ClinicalTrials.gov record NCT00140361. Inclusion in this directory is not an endorsement.